BRANCHBURG, N.J., Oct. 8 /PRNewswire-FirstCall/ -- LifeCell Corporation
(Nasdaq: LIFC), today announced plans to release third quarter 2007 operating
results on Thursday, October 25, 2007 at 8:00 a.m. Eastern.
The dial-in number for the live call is (888) 802-2279 /domestic or (913) 312-1265/international. A simultaneous webcast of the call will be available via LifeCell's website at www.lifecell.com Corporate Information - Investor Relations. The call will be archived on the Company's website for at least 90 days.
A recording of the live-call will be available through October 30, 2007 . The dial-in number to listen to the recording is (888) 203-1112 or (719) 457-0820. The replay access code is 7761410.
About LifeCell
LifeCell develops and markets innovative tissue repair products for use in reconstructive, orthopedic and urogynecologic surgical procedures. LifeCell's current marketed products include: AlloDerm(R) for plastic reconstructive, general surgical, burn and periodontal procedures; Cymetra(R), a particulate form of AlloDerm(R) suitable for injection; GraftJacket(R) for orthopedic applications and lower extremity wounds; AlloCraft(TM)DBM, for bone grafting procedures; and Repliform(R) for urogynecologic surgical procedures. The Company's research and development initiatives include programs focused on extending the use of its regenerative tissue matrix products into new surgical applications, as well as leveraging its core technology to other tissues, including non-human tissues, and expanding its product line in the rapidly growing biosurgery market. LifeCell maintains a website at www.lifecell.com.
SOURCE LifeCell Corporation
